No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ACRS Aclaris Therapeutics
- 2.720
- -0.050-1.81%
Close Dec 20 16:00 ET
- 3.000
- +0.280+10.29%
Post 20:01 ET
291.00MMarket Cap-5.23P/E (TTM)
2.900High2.710Low1.16MVolume2.740Open2.770Pre Close3.19MTurnover1.56%Turnover RatioLossP/E (Static)106.99MShares5.17052wk High2.24P/B202.58MFloat Cap0.85652wk Low--Dividend TTM74.48MShs Float33.880Historical High--Div YieldTTM6.86%Amplitude0.590Historical Low2.754Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Aclaris Therapeutics Inc -Files Prospectus for Offer, Resale by Selling Stockholders of up to 35.6 Mln Shares of Common Stock
Jefferies Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $7
Aclaris Therapeutics: Promising Pipeline and Strong Financial Outlook Drive Buy Rating
Stifel Maintains Aclaris Therapeutics(ACRS.US) With Hold Rating, Raises Target Price to $5
Stifel Nicolaus Remains a Hold on Aclaris Therapeutics (ACRS)
Sino biopharm (01177.HK) has reached a global cooperation agreement with博奥信 and aclaris therapeutics.
On December 5th, Gelonghui reported that sino biopharm (01177.HK) announced that the group has reached a global cooperation agreement with Aclaris Therapeutics, Inc. concerning their jointly developed TSLP monoclonal antibody "BSI-045B (TQC2731)" with Boaoxin Biotechnology (Nanjing) Co., Ltd. ("Boaoxin").
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock the Full List